Publications: Miss Sanushi Dambure Vithanachchi
Anderson S, Karlstaedt A, Chen J, Karatzia L, Barnes MR, Chen J, Albee LJ, Barnes MR et al.
.
Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy
.